Rapid response team-triggered procalcitonin measurement predicts infectious intensive care unit transfers

Critical Care Medicine

Volumn 40, Issue 7, 2012, Pages 2090-2095

  Wunderink, Richard G ^a   Diederich, Emily R ^c   Caramez, Maria Paula ^a   Donnelly, Helen K ^a   Norwood, Stephanie D ^b   Kho, Abel ^b   Reed, Kurt D ^b  

^a Pulmonary and Critical Care Division   (United States)

^b NORTHWESTERN UNIVERSITY   (United States)

^c UNIVERSITY OF KANSAS   (United States)

Author keywords

Biomarkers; procalcitonin; rapid response team; sepsis; systemic inflammatory response syndrome

Indexed keywords

PROCALCITONIN;

ADULT; AGED; CANCER PATIENT; FEMALE; HUMAN; INTENSIVE CARE UNIT; MAJOR CLINICAL STUDY; MALE; OBSERVATIONAL STUDY; PATIENT TRANSPORT; PILOT STUDY; PRIORITY JOURNAL; PROSPECTIVE STUDY; PROTEIN BLOOD LEVEL; PROTEIN DETERMINATION; RAPID RESPONSE TEAM; REVIEW; TERTIARY HEALTH CARE;

EID: 85027933511     PISSN: 00903493     EISSN: 15300293     Source Type: Journal    
DOI: 10.1097/CCM.0b013e31824fc027     Document Type: Review

References (21)

1. Buist M, Bernard S, Nguyen TV, et al: Association between clinically abnormal observations and subsequent in-hospital mortality: A prospective study. Resuscitation 2004; 62:137-141 (Pubitemid 39037257)
2. Buist MD, Moore GE, Bernard SA, et al: Effects of a medical emergency team on reduction of incidence of and mortality from unexpected cardiac arrests in hospital: Preliminary study. BMJ 2002; 324:387-390 (Pubitemid 34163899)
3. Joint Commission partners with IHI in 100,000 Lives Campaign. Jt Comm Perspect 2005; 25:1
4. Wachter RM, Pronovost PJ: The 100,000 Lives Campaign: A scientific and policy review. Jt Comm J Qual Patient Saf 2006; 32: 621-627
5. Ross TK: A second look at 100 000 lives campaign. Qual Manag Health Care 2009; 18:120-125
6. Chan PS, Jain R, Nallmothu BK, et al: Rapid response teams: A systematic review and meta-analysis. Arch Intern Med 2010; 170:18-26
7. Hillman K, Chen J, Cretikos M, et al; MERIT study investigators: Introduction of the medical emergency team (MET) system: A cluster-randomised controlled trial. Lancet 2005; 365:2091-2097 (Pubitemid 40826966)
8. Tee A, Calzavacca P, Licari E, et al: Bench-to-bedside review: The MET syndrome-the challenges of researching and adopting medical emergency teams. Crit Care 2008; 12:205
9. Edelson DP: A weak link in the rapid response system. Arch Intern Med 2010, 170:12-13.
10. Kho A, Rotz D, Alrahi K, et al: Utility of commonly captured data from an EHR to identify hospitalized patients at risk for clinical deterioration. AMIA Annu Symp Proc 2007:404-408
11. Smith GB, Prytherch DR, Schmidt P, et al: Hospital-wide physiological surveillance- A new approach to the early identification and management of the sick patient. Resuscitation 2006; 71:19-28 (Pubitemid 44332643)
12. DeVita MA, Smith GB, Adam SK, et al: "Identifying the hospitalised patient in crisis"- A consensus conference on the afferent limb of rapid response systems. Resuscitation 2010; 81:375-382
13. American College of Chest Physicians/Society of Critical Care Medicine Consensus Conference: Definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis. Crit Care Med 1992; 20:864-874
14. Hochreiter M, Köhler T, Schweiger AM, et al: Procalcitonin to guide duration of antibiotic therapy in intensive care patients: A randomized prospective controlled trial. Crit Care 2009; 13:R83
15. Kopterides P, Siempos II, Tsangaris I, et al: Procalcitonin-guided algorithms of antibiotic therapy in the intensive care unit: A systematic review and meta-analysis of randomized controlled trials. Crit Care Med 2010; 38:2229-2241
16. Nobre V, Harbarth S, Graf JD, et al: Use of procalcitonin to shorten antibiotic treatment duration in septic patients: A randomized trial. Am J Respir Crit Care Med 2008; 177:498-505 (Pubitemid 351442188)
17. Bouadma L, Luyt CE, Tubach F, et al:; PRORATA trial group: Use of procalcitonin to reduce patients' exposure to antibiotics in intensive care units (PRORATA trial): A multicentre randomised controlled trial. Lancet 2010; 375:463-474
18. Balci C, Sivaci R, Akbulut G, et al: Procalcitonin levels as an early marker in patients with multiple trauma under intensive care. J Int Med Res 2009; 37:1709-1717
19. Dornbusch HJ, Strenger V, Sovinz P, et al: Non-infectious causes of elevated procalcitonin and C-reactive protein serum levels in pediatric patients with hematologic and oncologic disorders. Support Care Cancer 2008; 16:1035-1040
20. Wild PS, Schnabel RB, Lubos E, et al: Midregional proadrenomedullin for prediction of cardiovascular events in coronary artery disease: Results from the AtheroGene study. Clin Chem 2012; 58:226-236
21. Albrich WC, Dusemund F, Rüegger K, et al: Enhancement of CURB65 score with proadrenomedullin (CURB65-A) for outcome prediction in lower respiratory tract infections: Derivation of a clinical algorithm. BMC Infect Dis 2011; 11:112